Your session is about to expire
← Back to Search
Initial Low dose for Stress
N/A
Waitlist Available
Led By Doug Delahanty, PhD
Research Sponsored by Kent State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Inclusion Criteria: Active Medical Personnel or First-Responders working during the COVID-19 Pandemic -
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 40 weeks
Awards & highlights
Study Summary
This trial is testing a toolkit of 3 activities to help with psychological resilience in medical personnel and first responders.
Eligible Conditions
- Stress
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 40 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~40 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Affective Experience
Patient Health Questionnaire - 4
Treatment Acceptability Questionnaire
+1 moreTrial Design
2Treatment groups
Active Control
Group I: Initial Low doseActive Control1 Intervention
Participants will receive only one daily positive emotion prompt in the first seven days of the toolkit use.
Group II: Initial high doseActive Control1 Intervention
Participants will receive two daily positive emotion prompts in the first seven days of use.
Find a Location
Who is running the clinical trial?
Kent State UniversityLead Sponsor
41 Previous Clinical Trials
5,593 Total Patients Enrolled
Doug Delahanty, PhDPrincipal InvestigatorKent State University
John Gunstad, PhDPrincipal InvestigatorKent State University
1 Previous Clinical Trials
200 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger